date,title,source
Oct-23-18,"Aptose to Release Third Quarter Ended September 30, 2018 Financial Results on November 6, 2018",GlobeNewswire
Nov-01-18,Aptose to Present New CG-806 Data at the 2018 ASH Annual Meeting,GlobeNewswire
Nov-06-18,Aptose Biosciences: 3Q Earnings Snapshot,Associated Press
Nov-06-18,"Aptose Reports Results for the Third Quarter Ended September 30, 2018",GlobeNewswire
Nov-14-18,"New Research: Key Drivers of Growth for WellCare Health Plans, Streamline Health Solutions, Aptose Biosciences, Houston Wire & Cable, RTI Surgical, and Atlantica Yield  Factors of Influence, Major Initiatives and Sustained Production",GlobeNewswire
Nov-20-18,"Aptose to Participate in Upcoming Investor Conferences, Host Key Opinion Leader Event, and Present Data at the Upcoming ASH Meeting",GlobeNewswire
Nov-26-18,Aptose Biosciences Doses First Patient in Re-Initiation of Phase 1b Clinical Study of APTO-253 in Relapsed or Refractory Hematological Malignancies,GlobeNewswire
Dec-03-18,OHSU and Aptose Present New CG-806 Preclinical Data at ASH 60th Annual Meeting,GlobeNewswire
Dec-03-18,Aptose Presents New Preclinical Data on CG-806 PAN-FLT3/PAN-BTK Inhibitor at ASH 60th Annual Meeting,GlobeNewswire
Dec-12-18,Aptose Presents Highlights From CG-806 KOL Event,GlobeNewswire
